Clinical Operations: Biggest Challenges Facing the Industry in 2020
I’m often asked, by clients across the globe, what the main Clinical Operations challenges facing pharma and biotech companies really are. Where are they investing their resources? What takes up their time? Where are their efforts going to be focused...
5 years agoClinical Operations: Biggest Challenges Facing the Industry in 2020
I’m often asked, by clients across the globe, what the main Clinical Operations challenges facing pharma and biotech companies really are. Where are they investing their resources? What takes up their time? Where are their efforts going to be focused...
5 years ago
The Changing Role of the Blockbuster Drug
There are few pharmaceutical companies not seeking the next big "blockbuster", a market drug earning revenue over $1 billion. These big-name products, which include Keytruda and Lipitor, are well-marketed and broadly-effective, often across several illnesses. For years scientists have worked...
5 years agoThe Changing Role of the Blockbuster Drug
There are few pharmaceutical companies not seeking the next big "blockbuster", a market drug earning revenue over $1 billion. These big-name products, which include Keytruda and Lipitor, are well-marketed and broadly-effective, often across several illnesses. For years scientists have worked...
5 years ago
Trending Innovations in Cold Chain Processes
As is increasingly known in the pharmaceutical industry, the rise in both trial costs and drug failures has seen a corresponding increase in the need for tight regulations and stricter procedures, to ensure the few successes are not further compromised....
5 years agoTrending Innovations in Cold Chain Processes
As is increasingly known in the pharmaceutical industry, the rise in both trial costs and drug failures has seen a corresponding increase in the need for tight regulations and stricter procedures, to ensure the few successes are not further compromised....
5 years agoInterested?
Reserve your space
